Applied Therapeutics Inc’s recently made public that its insider Funtleyder Leslie D. unloaded Company’s shares for reported $14000.0 on Feb 06 ’25. In the deal valued at $0.61 per share,22,950 shares were sold. As a result of this transaction, Funtleyder Leslie D. now holds 404,961 shares worth roughly $ 0.24 million.
Then, Perfetti Riccardo sold 86,078 shares, generating $52,508 in total proceeds. Upon selling the shares at $0.61, the Chief Medical Officer now owns 900,775 shares.
Before that, Chinoporos Constantine sold 28,117 shares. Applied Therapeutics Inc shares valued at $17,151 were divested by the insider at a price of $0.61 per share. As a result of the transaction, Chinoporos Constantine now holds 271,883 shares, worth roughly $0.16 million.
William Blair downgraded its Applied Therapeutics Inc [APLT] rating to a Mkt perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who decreased its forecast for the stock in early December from “a Buy” to “a Neutral”. RBC Capital Mkts also remained covering APLT and has decreased its forecast on November 29, 2024 with a “Sector perform” recommendation from previously “an Outperform” rating. William Blair started covering the stock on July 31, 2024. It rated APLT as “an Outperform”.
Price Performance Review of APLT
On Tuesday, Applied Therapeutics Inc [NASDAQ:APLT] saw its stock fall -8.90% to $0.59. Over the last five days, the stock has lost -1.55%. Applied Therapeutics Inc shares have fallen nearly -31.16% since the year began. Nevertheless, the stocks have fallen -78.01% over the past one year. While a 52-week high of $10.62 was reached on 01/02/25, a 52-week low of $0.54 was recorded on 02/12/25. SMA at 50 days reached $0.8078, while 200 days put it at $4.9207.
Levels Of Support And Resistance For APLT Stock
The 24-hour chart illustrates a support level at 0.5406, which if violated will result in even more drops to 0.4917. On the upside, there is a resistance level at 0.6684. A further resistance level may holdings at 0.7473. The Relative Strength Index (RSI) on the 14-day chart is 32.75, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0227, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 68.23%. Stochastics %K at 64.80% indicates the stock is a holding.
The most recent change occurred on March 26, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $12 price target.
